Centene (0HVB) Share Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0HVB Analyst Ratings

Moderate Buy

6 Buy

6 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Centene

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0HVB Stock 12 Month Forecast

Average Price Target

$73.70

▲(34.88%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $73.70 with a high forecast of $90.00 and a low forecast of $61.00. The average price target represents a 34.88% change from the last price of $54.64.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"56":"$56","91":"$91","64.75":"$64.8","73.5":"$73.5","82.25":"$82.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$90.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":73.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$73.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$61.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[56,64.75,73.5,82.25,91],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.86,62.17846153846154,64.49692307692308,66.81538461538462,69.13384615384615,71.4523076923077,73.77076923076923,76.08923076923077,78.40769230769232,80.72615384615385,83.04461538461538,85.36307692307693,87.68153846153847,{"y":90,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.86,60.924615384615386,61.98923076923077,63.05384615384615,64.11846153846155,65.18307692307692,66.2476923076923,67.3123076923077,68.37692307692308,69.44153846153847,70.50615384615385,71.57076923076923,72.63538461538462,{"y":73.7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,59.86,59.94769230769231,60.035384615384615,60.12307692307692,60.21076923076923,60.29846153846154,60.386153846153846,60.473846153846154,60.56153846153846,60.64923076923077,60.73692307692308,60.824615384615385,60.91230769230769,{"y":61,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":72.96,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.75,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.13,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.42,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.887,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.74,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.085,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.283,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.09,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.475,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.647,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$90.00

Average Price Target$73.70

Lowest Price Target$61.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$90

Buy

64.71%

Upside

Reiterated

05/16/25

Cantor Fitzgerald reiterates Overweight Rating on Centene (CNC)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $90.00 price target on Centene (NYSE: CNC).

Stephen BaxterWells Fargo

Wells Fargo

$72

Buy

31.77%

Upside

Reiterated

05/12/25

Wells Fargo Sticks to Its Buy Rating for Centene (CNC)

Lance WilkesBernstein

Bernstein

$81→$86

Buy

57.39%

Upside

Reiterated

05/08/25

Centene (CNC) PT Raised to $86 at Bernstein SocGen GroupBernstein SocGen Group analyst Lance Wilkes raised the price target on Centene (NYSE: CNC) to $86.00 (from $81.00) while maintaining a Outperform rating.

Andrew Mok CFABarclays

Barclays

$84

Buy

53.73%

Upside

Reiterated

04/30/25

Centene (CNC) Gets a Buy from Barclays

David WindleyJefferies

Jefferies

$64→$61

Hold

11.64%

Upside

Reiterated

04/29/25

Centene price target lowered to $61 from $64 at JefferiesCentene price target lowered to $61 from $64 at Jefferies

Michael WiederhornOppenheimer

Oppenheimer

$85

Buy

55.56%

Upside

Reiterated

04/28/25

Oppenheimer Sticks to Its Buy Rating for Centene (CNC)

David S MacdonaldTruist Financial

Truist Financial

―

Buy

―

Reiterated

04/28/25

Truist Financial Keeps Their Buy Rating on Centene (CNC)

Joanna GajukBank of America Securities

Bank of America Securities

$72.5→$65

Hold

18.96%

Upside

Reiterated

04/28/25

Analysts Conflicted on These Healthcare Names: Centene (NYSE: CNC), Merck & Company (NYSE: MRK) and Galapagos (NASDAQ: GLPG)

Ryan LangstonTD Cowen

TD Cowen

$80→$73

Buy

33.60%

Upside

Reiterated

04/28/25

Centene's Strategic Growth and Stability Justify Buy Rating Despite Price Target Adjustment

Michael HaRobert W. Baird

Robert W. Baird

$71→$69

Hold

26.28%

Upside

Reiterated

04/14/25

Centene price target lowered to $69 from $71 at BairdCentene price target lowered to $69 from $71 at Baird

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Initiated

04/08/25

Guggenheim starts Centene (CNC) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on Centene (NYSE: CNC) with a Neutral rating.

Ann HynesMizuho Securities

Mizuho Securities

$71

Hold

29.94%

Upside

Reiterated

03/05/25

Mizuho Securities Sticks to Their Hold Rating for Centene (CNC)

John StaszakArgus Research

Argus Research

―

Hold

―

Downgraded

02/05/25

Centene downgraded to Hold from Buy at ArgusCentene downgraded to Hold from Buy at Argus

John StanselJ.P. Morgan

J.P. Morgan

$80→$75

Buy

37.26%

Upside

Upgraded

12/17/24

Centene assumed with Overweight from Neutral at JPMorganCentene assumed with Overweight from Neutral at JPMorgan

A.J. RiceUBS

UBS

$80

Buy

46.41%

Upside

Upgraded

12/13/24

Centene's Undervaluation and Strategic Growth Positions: A Buy Recommendation by A.J. Rice

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$90

Buy

64.71%

Upside

Reiterated

05/16/25

Cantor Fitzgerald reiterates Overweight Rating on Centene (CNC)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $90.00 price target on Centene (NYSE: CNC).

Stephen BaxterWells Fargo

Wells Fargo

$72

Buy

31.77%

Upside

Reiterated

05/12/25

Wells Fargo Sticks to Its Buy Rating for Centene (CNC)

Lance WilkesBernstein

Bernstein

$81→$86

Buy

57.39%

Upside

Reiterated

05/08/25

Andrew Mok CFABarclays

Barclays

$84

Buy

53.73%

Upside

Reiterated

04/30/25

Centene (CNC) Gets a Buy from Barclays

David WindleyJefferies

Jefferies

$64→$61

Hold

11.64%

Upside

Reiterated

04/29/25

Centene price target lowered to $61 from $64 at JefferiesCentene price target lowered to $61 from $64 at Jefferies

Michael WiederhornOppenheimer

Oppenheimer

$85

Buy

55.56%

Upside

Reiterated

04/28/25

Oppenheimer Sticks to Its Buy Rating for Centene (CNC)

David S MacdonaldTruist Financial

Truist Financial

―

Buy

―

Reiterated

04/28/25

Truist Financial Keeps Their Buy Rating on Centene (CNC)

Joanna GajukBank of America Securities

Bank of America Securities

$72.5→$65

Hold

18.96%

Upside

Reiterated

04/28/25

Analysts Conflicted on These Healthcare Names: Centene (NYSE: CNC), Merck & Company (NYSE: MRK) and Galapagos (NASDAQ: GLPG)

Ryan LangstonTD Cowen

TD Cowen

$80→$73

Buy

33.60%

Upside

Reiterated

04/28/25

Centene's Strategic Growth and Stability Justify Buy Rating Despite Price Target Adjustment

Michael HaRobert W. Baird

Robert W. Baird

$71→$69

Hold

26.28%

Upside

Reiterated

04/14/25

Centene price target lowered to $69 from $71 at BairdCentene price target lowered to $69 from $71 at Baird

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Initiated

04/08/25

Guggenheim starts Centene (CNC) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on Centene (NYSE: CNC) with a Neutral rating.

Ann HynesMizuho Securities

Mizuho Securities

$71

Hold

29.94%

Upside

Reiterated

03/05/25

Mizuho Securities Sticks to Their Hold Rating for Centene (CNC)

John StaszakArgus Research

Argus Research

―

Hold

―

Downgraded

02/05/25

Centene downgraded to Hold from Buy at ArgusCentene downgraded to Hold from Buy at Argus

John StanselJ.P. Morgan

J.P. Morgan

$80→$75

Buy

37.26%

Upside

Upgraded

12/17/24

Centene assumed with Overweight from Neutral at JPMorganCentene assumed with Overweight from Neutral at JPMorgan

A.J. RiceUBS

UBS

$80

Buy

46.41%

Upside

Upgraded

12/13/24

Centene's Undervaluation and Strategic Growth Positions: A Buy Recommendation by A.J. Rice

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

1 Month

xxx

Success Rate

20/30 ratings generated profit

Average Return

+2.86%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.86% per trade.

3 Months

xxx

Success Rate

35/52 ratings generated profit

Average Return

+4.40%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.31% of your transactions generating a profit, with an average return of +4.40% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

29/52 ratings generated profit

Average Return

+12.09%

reiterated a buy rating last month

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 55.77% of your transactions generating a profit, with an average return of +12.09% per trade.

2 Years

xxx

Success Rate

18/30 ratings generated profit

Average Return

+12.20%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +12.20% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0HVB Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0HVB has received 17 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 0HVB average Analyst price target in the past 3 months is 73.70.

Each month's total comprises the sum of three months' worth of ratings.

0HVB Financial Forecast

0HVB Earnings Forecast

Next quarter’s earnings estimate for 0HVB is $2.02 with a range of $1.60 to $2.30. The previous quarter’s EPS was $2.90. 0HVB beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.06% of the time in the same period. In the last calendar year 0HVB has Outperformed its overall industry.

0HVB Sales Forecast

Next quarter’s sales forecast for 0HVB is $44.68B with a range of $42.96B to $46.30B. The previous quarter’s sales results were $46.62B. 0HVB beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year 0HVB has Outperformed its overall industry.

0HVB Stock Forecast FAQ

What is GB:0HVB’s average 12-month price target, according to analysts?

Based on analyst ratings, Centene’s 12-month average price target is 73.70.

What is GB:0HVB’s upside potential, based on the analysts’ average price target?

Centene has 34.88% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Centene a Buy, Sell or Hold?

Centene has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.

What is Centene’s share price target?

The average share price target for Centene is 73.70. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $90.00 ,and the lowest forecast is $61.00. The average share price target represents 34.88% Increase from the current price of $54.64.

What do analysts say about Centene?

Centene’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Centene?

To buy shares of GB:0HVB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Centene (0HVB) Share Forecast & Price Target

0HVB Analyst Ratings

0HVB Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Centene

0HVB Analyst Recommendation Trends

0HVB Financial Forecast

0HVB Earnings Forecast

0HVB Sales Forecast

0HVB Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts